14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 05, 2024 Buy 17 847 Morisset Valerie Common Stock
Apr 05, 2024 Sell 17 847 Morisset Valerie Stock Option (Right to Buy)
Mar 18, 2024 Buy 40 000 Pimblett Emily Restricted Stock Units
Sep 20, 2023 Buy 15 297 Morisset Valerie Common Stock
Sep 20, 2023 Buy 5 431 Morisset Valerie Common Stock
Sep 20, 2023 Sell 15 297 Morisset Valerie Stock Option (Right to Buy)
Sep 20, 2023 Sell 5 431 Morisset Valerie Stock Option (Right to Buy)
May 18, 2023 Buy 10 000 Ra Capital Management, L.p. Stock Option (Right to Buy)
May 18, 2023 Buy 10 000 Tate Simon Stock Option (Right To Buy)
May 18, 2023 Buy 10 000 Ratcliffe Liam Stock Option (Right To Buy)
May 18, 2023 Buy 10 000 Dunn Judith Stock Option (Right To Buy)
May 18, 2023 Buy 10 000 Rosenberg Adam Joseph Stock Option (Right To Buy)
May 18, 2023 Buy 10 000 Levin Andrew David Stock Option (Right To Buy)
Mar 13, 2023 Buy 35 000 Pimblett Emily Stock Option (Right to Buy)
Mar 13, 2023 Buy 30 000 Pimblett Emily Stock Option (Right to Buy)
Mar 13, 2023 Buy 30 000 Pimblett Emily Stock Option (Right to Buy)
Mar 10, 2023 Buy 61 191 Morisset Valerie Common Stock
Mar 10, 2023 Buy 255 219 Morisset Valerie Common Stock
Mar 10, 2023 Sell 61 191 Morisset Valerie Stock Option (Right to Buy)
Mar 10, 2023 Sell 255 219 Morisset Valerie Stock Option (Right to Buy)
Oct 31, 2022 Buy 170 000 Morisset Valerie Stock Option (Right to Buy)
Oct 31, 2022 Buy 500 000 Azelby Robert Stock Option (Right to Buy)
Oct 31, 2022 Buy 170 000 Lavelle Erin Stock Option (Right to Buy)
Oct 31, 2022 Buy 95 000 Bucher James B Stock Option (Right to Buy)
May 19, 2022 Buy 10 000 Tate Simon Stock Option (Right To Buy)
May 19, 2022 Buy 10 000 Shah Rajeev M. Stock Option (Right to Buy)
May 19, 2022 Buy 10 000 Ra Capital Management, L.p. Stock Option (Right to Buy)
May 19, 2022 Buy 10 000 Ratcliffe Liam Stock Option (Right To Buy)
May 19, 2022 Buy 10 000 Ratcliffe Liam Stock Option (Right To Buy)
May 19, 2022 Buy 10 000 Patterson Leone D Stock Option (Right To Buy)
May 19, 2022 Buy 10 000 Patterson Leone D Stock Option (Right To Buy)
May 19, 2022 Buy 10 000 Rosenberg Adam Joseph Stock Option (Right To Buy)
May 19, 2022 Buy 10 000 Levin Andrew David Stock Option (Right to Buy)
May 19, 2022 Buy 10 000 Dunn Judith Stock Option (Right To Buy)
Jan 27, 2022 Buy 170 000 Lavelle Erin Stock Option (Right to Buy)
Jan 27, 2022 Buy 500 000 Azelby Robert Stock Option (Right to Buy)
Jan 27, 2022 Buy 170 000 Morisset Valerie Stock Option (Right to Buy)
Jan 27, 2022 Buy 95 000 Bucher James B Stock Option (Right to Buy)
Aug 12, 2021 Buy 3 004 782 Ra Capital Management, L.p. Common Stock
Aug 12, 2021 Buy 4 727 585 Ra Capital Management, L.p. Common Stock
Aug 12, 2021 Buy 1 226 497 Ra Capital Management, L.p. Common Stock
Aug 12, 2021 Buy 624 974 Ra Capital Management, L.p. Common Stock
Aug 12, 2021 Buy 195 218 Ra Capital Management, L.p. Common Stock
Aug 12, 2021 Buy 288 461 Ra Capital Management, L.p. Common Stock
Aug 12, 2021 Sell 485 493 Ra Capital Management, L.p. Series A Preferred Stock
Aug 12, 2021 Sell 139 481 Ra Capital Management, L.p. Series A-1 Preferred Stock
Aug 12, 2021 Sell 288 461 Ra Capital Management, L.p. Series B Preferred Stock
Aug 12, 2021 Buy 800 000 Ai Eti Llc Common Stock
Aug 12, 2021 Buy 4 209 400 Ai Eti Llc Common Stock
Aug 12, 2021 Sell 3 568 375 Ai Eti Llc Series A Redeemable Convertible Preferred Stock
Aug 12, 2021 Sell 641 025 Ai Eti Llc Series B Redeemable Convertible Preferred Stock
Aug 09, 2021 Buy 20 000 Ra Capital Management, L.p. Stock Option (Right to Buy)
Aug 09, 2021 Buy 20 000 Ratcliffe Liam Stock Option (Right to Buy)
Aug 09, 2021 Buy 20 000 Rosenberg Adam Joseph Stock Option (Right to Buy)
Aug 09, 2021 Buy 20 000 Tate Simon Stock Option (Right to Buy)
Aug 09, 2021 Buy 20 000 Levin Andrew David Stock Option (Right to Buy)
Aug 09, 2021 Buy 3 568 375 Ai Eti Llc Series A Redeemable Convertible Preferred Stock
Aug 09, 2021 Buy 641 025 Ai Eti Llc Series B Redeemable Convertible Preferred Stock
Aug 09, 2021 Buy 39 198 Dunn Judith Stock Option (Right to Buy)
Aug 09, 2021 Buy 15 383 Dunn Judith Stock Option (Right to Buy)
Aug 09, 2021 Buy 39 198 Patterson Leone D Stock Option (Right to Buy)
Aug 09, 2021 Buy 15 383 Patterson Leone D Stock Option (Right to Buy)
Aug 09, 2021 Buy 0 Ratcliffe Liam No securities are beneficially owned.
Aug 09, 2021 Buy 0 Rosenberg Adam Joseph Common Stock
Aug 09, 2021 Buy 0 Tate Simon No securities are beneficially owned.
Aug 09, 2021 Buy 0 Ra Capital Management, L.p. Common Stock
Aug 09, 2021 Buy 0 Ra Capital Management, L.p. Common Stock
Aug 09, 2021 Buy 485 493 Ra Capital Management, L.p. Series A Preferred Stock
Aug 09, 2021 Buy 139 481 Ra Capital Management, L.p. Series A-1 Preferred Stock
Aug 09, 2021 Buy 288 461 Ra Capital Management, L.p. Series B Preferred Stock
Aug 09, 2021 Buy 0 Levin Andrew David No securities are beneficially owned.
Aug 09, 2021 Buy 130 661 Bucher James B Stock Option (Right to Buy)
Aug 09, 2021 Buy 67 749 Bucher James B Stock Option (Right to Buy)
Aug 09, 2021 Buy 235 190 Lavelle Erin Stock Option (Right to Buy)
Aug 09, 2021 Buy 121 948 Lavelle Erin Stock Option (Right to Buy)
Aug 09, 2021 Buy 0 Morisset Valerie Common Stock
Aug 09, 2021 Buy 260 650 Morisset Valerie Stock Option (Right to Buy)
Aug 09, 2021 Buy 122 381 Morisset Valerie Stock Option (Right to Buy)
Aug 09, 2021 Buy 783 968 Azelby Robert Stock Option (Right to Buy)
Aug 09, 2021 Buy 406 494 Azelby Robert Stock Option (Right to Buy)
INSIDER POWER
49.101
Last 80 transactions
Buy: 25 057 940 | Sell: 5 477 820 (Shares)

Based on the 80 latest insides trades, we have calculated the insider power to be positive at a ratio of 49.101.

In total, the insiders bought 25 057 940 and sold 5 477 820 ELYM shares in the last 80 trades.

Click to get the best stock tips daily for free!

About Eliem Therapeutics, Inc.

Eliem Therapeutics. Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression... ELYM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT